AJP Reports最新文献

筛选
英文 中文
Short-Term Outcomes in Neonates Born to Diabetic Mothers During the Coronavirus Disease 2019 Pandemic: A Descriptive Study. 2019冠状病毒病大流行期间糖尿病母亲所生新生儿的短期结局:一项描述性研究
IF 0.7
AJP Reports Pub Date : 2026-06-16 eCollection Date: 2026-04-01 DOI: 10.1055/a-2860-5934
Anfal Awwadh Alshalawi, Michael R Miller, Malack Turki Alotayan, Khalid Faisal Alkahtani, Adnan Hadid, Nada Alayed, Lana A Shaiba, Orlando Pereira Da Silva
{"title":"Short-Term Outcomes in Neonates Born to Diabetic Mothers During the Coronavirus Disease 2019 Pandemic: A Descriptive Study.","authors":"Anfal Awwadh Alshalawi, Michael R Miller, Malack Turki Alotayan, Khalid Faisal Alkahtani, Adnan Hadid, Nada Alayed, Lana A Shaiba, Orlando Pereira Da Silva","doi":"10.1055/a-2860-5934","DOIUrl":"10.1055/a-2860-5934","url":null,"abstract":"<p><p><b>Background</b> Gestational diabetes mellitus (GDM) negatively affects newborns. Several studies have reported new-onset diabetes associated with coronavirus disease 2019 (COVID-19). Multiple pathophysiological mechanisms have been proposed to explain the relationship between COVID-19 and glycemic dysregulation in neonates. We assessed neonatal outcomes among mothers with diabetes during the COVID-19 pandemic. <b>Methods</b> This retrospective descriptive study included mothers with diabetes (Type 1, Type 2, and GDM) who were COVID-19 positive at least 24 h before delivery and those who were negative, to compare newborn outcomes. The study was conducted at King Saud University Medical City, Riyadh, from January 2020 to December 2022. <b>Results</b> A total of 669 diabetic mothers were included; 23 were COVID-19 positive at delivery. Sixteen had Type 1, 59 had Type 2, and 572 had GDM. Most managed diabetes by diet. Among newborns, 128 (18.6%) in the COVID-19-negative group and 8 (34.8%) in the COVID-19-positive group developed hypoglycemia. Of these, 105 required neonatal intensive care unit (NICU) admission. Most were treated with intravenous dextrose, and five needed glucagon. Mean NICU stay was 12.9 days for negatives and 7 days for positives. One intrauterine fetal death occurred in the negative group. <b>Conclusion</b> Hypoglycemia occurred mainly within the 1 h and resolved with early feeding. Immediate postnatal feeding and screening at 2 h are recommended. No significant differences were found in short-term neonatal outcomes between COVID-19-positive and negative mothers.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e109-e113"},"PeriodicalIF":0.7,"publicationDate":"2026-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13286096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148306565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractory Neonatal Apnea Revealing Congenital Central Hypoventilation Syndrome: Improved Outcome through Early Multidisciplinary Intervention. 难治性新生儿呼吸暂停揭示先天性中枢性低通气综合征:通过早期多学科干预改善预后。
IF 0.7
AJP Reports Pub Date : 2026-06-02 eCollection Date: 2026-04-01 DOI: 10.1055/a-2873-6868
Michal M Shalamov, Linsey R Cromwell, Pallabi Guha
{"title":"Refractory Neonatal Apnea Revealing Congenital Central Hypoventilation Syndrome: Improved Outcome through Early Multidisciplinary Intervention.","authors":"Michal M Shalamov, Linsey R Cromwell, Pallabi Guha","doi":"10.1055/a-2873-6868","DOIUrl":"10.1055/a-2873-6868","url":null,"abstract":"<p><p><b>Background:</b> Congenital central hypoventilation syndrome (CCHS) is a rare genetic disorder that causes alveolar hypoventilation because of impaired chemoreceptor response to hypercapnia and hypoxia occurring due to a dysfunctional central autonomic drive. CCHS is a result of pathogenic variants of the <i>PHOX2B</i> gene, which affects neural crest cell development. Consequently, CCHS can be accompanied by dysregulation of the autonomic system, Hirschsprung's disease and other gastrointestinal disorders, cardiac arrhythmias, and neural cell-derived tumors. Disease severity correlates with mutation type and determines ventilatory requirements, with management centered on lifelong respiratory support and multidisciplinary monitoring for associated comorbidities. <b>Case Presentation:</b> This case describes a term infant delivered via emergency cesarean section for maternal hypotension and fetal bradycardia who presented with apnea and required intubation due to failure to respond to positive pressure ventilation. The infant experienced recurrent apnea, hypercarbia, and ventilator dependence due to multiple failed extubation attempts, with an unrevealing evaluation for pulmonary, cardiac, neurologic, metabolic, and infectious causes. Genetic testing identified a <i>PHOX2B</i> polyalanine repeat expansion consistent with CCHS. This case demonstrates a stepwise multidisciplinary approach with concurrent genetic evaluation that enabled early diagnosis, timely management, and improved outcome.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e105-e108"},"PeriodicalIF":0.7,"publicationDate":"2026-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13288275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148315299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sickle Cell Vaso-Occlusive Crisis Leading to Uteroplacental Malperfusion: A Case Report. 镰状细胞血管闭塞危像导致子宫胎盘灌注不良1例报告。
IF 0.7
AJP Reports Pub Date : 2026-04-29 eCollection Date: 2026-04-01 DOI: 10.1055/a-2849-8204
Annika van Oosbree, Gretchen Hahn, Sarah Shea
{"title":"Sickle Cell Vaso-Occlusive Crisis Leading to Uteroplacental Malperfusion: A Case Report.","authors":"Annika van Oosbree, Gretchen Hahn, Sarah Shea","doi":"10.1055/a-2849-8204","DOIUrl":"10.1055/a-2849-8204","url":null,"abstract":"<p><p><b>Background</b> Sickle cell disease (SCD) in pregnancy is associated with substantially increased risks of stillbirth and neonatal death due to vaso-occlusive crises, chronic anemia, and impaired placental perfusion. <b>Case</b> We present the case of a 25-year-old primigravida with HbSS disease who presented at 29 weeks' gestation with a vaso-occlusive pain crisis. Although she was initially clinically stable with reassuring fetal testing, she developed acute fetal distress on hospital day 3, prompting an emergent cesarean delivery. Intraoperatively, the uterus appeared profoundly hypoperfused with minimal bleeding despite uterine atony. The neonate was delivered in asystole and required prolonged resuscitation. Postresuscitation examination raised concern for severe hypoxic ischemic encephalopathy, and the parents elected to transition to comfort care. The neonate died shortly after withdrawal of life-sustaining interventions. Placental pathology demonstrated prominent sickled erythrocytes and increased fetal nucleated red blood cells, consistent with prolonged impaired oxygen delivery. <b>Conclusion</b> This case highlights the unpredictable and acute nature of fetal compromise in pregnancies complicated by SCD, which may occur prior to guideline-recommended antenatal surveillance. Although prophylactic transfusion remains controversial, emerging evidence suggests a potential benefit in selecting high-risk patients. Early multidisciplinary management, individualized transfusion strategies, and heightened vigilance for sudden fetal decompensation are essential to improving perinatal outcomes in SCD.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e96-e100"},"PeriodicalIF":0.7,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13129312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147809382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital Thrombocytosis, Hepatosplenomegaly, and Rash in a Term Neonate. 足月新生儿的先天性血小板增多、肝脾肿大和皮疹。
IF 0.7
AJP Reports Pub Date : 2026-04-29 eCollection Date: 2026-04-01 DOI: 10.1055/a-2851-8535
Michal Mia Shalamov, Akshara Vadyala, Nirzar Parikh, Jessica Scerbo, Estephanie Rivero
{"title":"Congenital Thrombocytosis, Hepatosplenomegaly, and Rash in a Term Neonate.","authors":"Michal Mia Shalamov, Akshara Vadyala, Nirzar Parikh, Jessica Scerbo, Estephanie Rivero","doi":"10.1055/a-2851-8535","DOIUrl":"10.1055/a-2851-8535","url":null,"abstract":"<p><p><b>Objective</b> Transient abnormal myelopoiesis (TAM) is a self-limited clonal myeloproliferative disorder seen almost exclusively in neonates with trisomy 21 and defined by circulating myeloblasts carrying N-terminal truncating GATA1 mutations. Although most cases occur in infants with typical Down syndrome features, TAM can arise in clinically normal newborns with mosaic trisomy 21, creating significant diagnostic uncertainty. <b>Study Design</b> We report a term female neonate who presented with pallor, respiratory distress, hepatosplenomegaly, and a papular, nonblanching rash. <b>Results</b> Laboratory studies showed marked thrombocytosis, leukocytosis, and numerous circulating blasts. Flow cytometry detected a 17% abnormal blast population resembling congenital acute myeloid leukemia, but bone marrow aspirate revealed a myeloproliferative picture without definitive malignancy, favoring TAM. Molecular testing confirmed a truncating GATA1 mutation and mosaic trisomy 21 by SNP array, fluorescence in situ hybridization, and microarray. The infant's condition improved rapidly, with resolution of organomegaly and normalization of blood counts in the first week of life. <b>Conclusion</b> This case underscores the diagnostic challenges of TAM in phenotypically normal infants. Because clinical and laboratory findings can closely mimic congenital leukemia, early evaluation for GATA1 mutations and trisomy 21 is essential to establish the correct diagnosis, guide management, and avoid unnecessary chemotherapy.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e101-e104"},"PeriodicalIF":0.7,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13288590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148315343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concordant Open Neural Tube Defects in a Monochorionic Twin Pair of a Dichorionic-Triamniotic Triplet Gestation. 双绒毛膜-三羊膜三胞胎妊娠的单绒毛膜双胞胎一致开放神经管缺陷。
IF 0.7
AJP Reports Pub Date : 2026-04-22 eCollection Date: 2026-04-01 DOI: 10.1055/a-2848-3193
Olivia Van Benschoten, Lauryn Gabby, Shreya Visvanathan, Ashlyn Hodges, Lori Moore, Martin Olsen, Aleksandr Fuks
{"title":"Concordant Open Neural Tube Defects in a Monochorionic Twin Pair of a Dichorionic-Triamniotic Triplet Gestation.","authors":"Olivia Van Benschoten, Lauryn Gabby, Shreya Visvanathan, Ashlyn Hodges, Lori Moore, Martin Olsen, Aleksandr Fuks","doi":"10.1055/a-2848-3193","DOIUrl":"10.1055/a-2848-3193","url":null,"abstract":"<p><p><b>Introduction</b> Myelomeningocele (MMC) is a type of open neural defect that involves exposure of the meninges and neural elements. There are fewer than 30 cases of twins with concordant MMCs reported in the literature. We discuss a case of dichorionic-triamniotic triplets in which the monochorionic-diamniotic pair was diagnosed antenatally with MMC. <b>Case Summary</b> The mother presented for routine prenatal care at 11 weeks of gestation as a 31-year-old G5P4003. A limited ultrasound at 18 weeks of gestation confirmed her estimated due date, and three viable fetuses were observed. She was found to have dichorionic-triamniotic triplets with Triplet A and Triplet B sharing a placenta. A detailed anatomic survey demonstrated MMC of Triplet B at L4-S2 and a suspected open neural tube defect in Triplet A. Triplet C had no apparent defects on ultrasound. MMC of Triplets A and B was confirmed postnatally. Chromosome microarray analyses for the triplets were normal. <b>Discussion</b> Most cases of MMC in monozygotic twins are nonconcordant, and the role of genetics remains ambiguous. Our case suggests a possible shared genetic etiology. Future studies may investigate the potential for a single-gene mutation driving the development of MMC.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e93-e95"},"PeriodicalIF":0.7,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13288591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148315270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discrepant Results on Two Different Single Gene Non-invasive Prenatal Tests for Cystic Fibrosis: A Case Report. 囊性纤维化两种不同单基因无创产前检查的差异结果:1例报告。
IF 0.7
AJP Reports Pub Date : 2026-04-20 eCollection Date: 2026-04-01 DOI: 10.1055/a-2844-4548
James P Hogg
{"title":"Discrepant Results on Two Different Single Gene Non-invasive Prenatal Tests for Cystic Fibrosis: A Case Report.","authors":"James P Hogg","doi":"10.1055/a-2844-4548","DOIUrl":"10.1055/a-2844-4548","url":null,"abstract":"<p><p><b>Background</b> Prenatal cell-free DNA (cfDNA) screening has revolutionized the prenatal detection of fetal aneuploidy and other conditions. Originally designed to identify risk for trisomy 21, cfDNA screening has expanded to other fetal aneuploidies, microdeletion syndromes, dominant de novo single-gene disorders, and now autosomal-recessive single-gene conditions. The advancement of cfDNA screening offers patients and providers more options for prenatal risk assessment. <b>Case</b> A 34-year-old G2P1001 patient received a false-negative result from one single-gene noninvasive prenatal testing (sgNIPT), also known as prenatal single-gene cfDNA screening, for fetal cystic fibrosis, followed by a discrepant true-positive result on a different sgNIPT platform. The patient has a prior child affected with cystic fibrosis. The second laboratory returned a high-risk result for fetal cystic fibrosis, which was confirmed with diagnostic amniocentesis. <b>Conclusion</b> Prenatal sgNIPT screening should be individualized after appropriate counseling on the benefits and limitations of available screening and diagnostic tests. While diagnostic amniocentesis remains the society-recommended gold standard for prenatal diagnosis of autosomal-recessive conditions, these new, noninvasive technologies provide more options for patients who either do not want to assume the risks associated with or to better guide decision-making for diagnostic testing.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e90-e92"},"PeriodicalIF":0.7,"publicationDate":"2026-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13095397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147759827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late-Onset Hypoparathyroidism-Induced Hypocalcemia in a Very Low Birth Weight Infant Caused by Undiagnosed Maternal Hyperparathyroidism. 未确诊的母亲甲状旁腺功能亢进引起的迟发性甲状旁腺功能低下引起的极低出生体重婴儿低钙血症。
IF 0.7
AJP Reports Pub Date : 2026-04-14 eCollection Date: 2026-04-01 DOI: 10.1055/a-2837-6826
Arne Beyer, Meike Franssen, Kai Böckenholt, Jonas Rohde, Ester Domning, Florian Schneider
{"title":"Late-Onset Hypoparathyroidism-Induced Hypocalcemia in a Very Low Birth Weight Infant Caused by Undiagnosed Maternal Hyperparathyroidism.","authors":"Arne Beyer, Meike Franssen, Kai Böckenholt, Jonas Rohde, Ester Domning, Florian Schneider","doi":"10.1055/a-2837-6826","DOIUrl":"10.1055/a-2837-6826","url":null,"abstract":"<p><strong>Objective: </strong>To describe a rare case of late-onset neonatal hypocalcemia in a very preterm infant caused by maternal adenoma-related hyperparathyroidism (HyperPT) and to discuss diagnostic and therapeutic implications.</p><p><strong>Study design: </strong>Case report of a preterm infant born at 29 weeks of gestation with very low birth weight. Clinical course, laboratory findings, maternal history, and management were reviewed to identify the etiology and guide treatment.</p><p><strong>Results: </strong>The infant developed transient, asymptomatic hypocalcemia during the neonatal period. Maternal evaluation revealed primary HyperPT due to a parathyroid adenoma as the underlying cause. The newborn responded to calcium supplementation and optimized vitamin D therapy.</p><p><strong>Conclusion: </strong>Maternal HyperPT can cause delayed neonatal hypocalcemia even in preterm infants. Early recognition through coordinated maternal-neonatal evaluation is crucial. Optimal vitamin D administration and close interdisciplinary communication between obstetrics and neonatology are essential for prevention and management.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e83-e89"},"PeriodicalIF":0.7,"publicationDate":"2026-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13078914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147687677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chorionic Villi Sampling among Early and Late Gestational Age: Does Timing Affect Yield and Outcomes? 早、晚胎龄的绒毛膜绒毛取样:时间是否影响产出率和结局?
IF 0.7
AJP Reports Pub Date : 2026-04-07 eCollection Date: 2026-04-01 DOI: 10.1055/a-2837-7068
Julia Kim, Amberly Lao, Annie Rozenblyum, Lamia Alamri, Abigail Ludwigson, Teresa Dunn, Andrei Rebarber, Jennifer Lam-Rachlin, Manesha Putra, Martin Chavez, Patricia Rekawek, Lakha Prasannan
{"title":"Chorionic Villi Sampling among Early and Late Gestational Age: Does Timing Affect Yield and Outcomes?","authors":"Julia Kim, Amberly Lao, Annie Rozenblyum, Lamia Alamri, Abigail Ludwigson, Teresa Dunn, Andrei Rebarber, Jennifer Lam-Rachlin, Manesha Putra, Martin Chavez, Patricia Rekawek, Lakha Prasannan","doi":"10.1055/a-2837-7068","DOIUrl":"10.1055/a-2837-7068","url":null,"abstract":"<p><strong>Background: </strong>Chorionic villus sampling (CVS) is a diagnostic procedure that can be performed between 10 <sup>0/7</sup> and 13 <sup>6/7</sup> weeks to detect genetic abnormalities; however, a majority of providers opt to perform CVS after 11 weeks. This study evaluated the feasibility of CVS performed at varying gestational ages, comparing chorionic villi (CV) yield and procedural outcomes among early, typical, and late procedures.</p><p><strong>Materials and methods: </strong>This multicenter retrospective study included patients with CVS categorized as early (10 <sup>0/7</sup> -10 <sup>6/7</sup> weeks), typical (11 <sup>0/7</sup> -13 <sup>6/7</sup> weeks), and late CVS (≥14 <sup>0/7</sup> weeks). The primary outcome was median CV weight. Secondary outcomes included need for culture, time to microarray results, and a subanalysis of abnormal chromosomal microarray analysis (CMA) results, obstetric, and neonatal outcomes.</p><p><strong>Results: </strong>Of 719 patients, 8.1% underwent early, 83.2% typical, and 8.8% late CVS. The early cohort had a lower body mass index (BMI). Early CVS was most frequently performed transvaginally and for the indication of prior affected pregnancy, and less likely for abnormal genetic screening or ultrasound findings. Median villi weight did not differ significantly, and 89% of all procedures yielded adequate tissue, defined as ≥5 mg. The time to the microarray result was shortest in the typical group. There were no significant differences in other secondary outcomes of need for culture, number of passes, or procedure-related complication rates. There was no case of limb anomalies.</p><p><strong>Conclusion: </strong>CVS performed before 11 weeks and after 14 weeks demonstrated comparable microarray outcomes and demonstrate the technical feasibility and diagnostic adequacy of CVS performed outside the typical gestational window. The results also support the availability of early CVS for cytogenetic testing in early pregnancy loss, where management may not allow for direct tissue testing. Prospective studies are warranted to validate these results and refine recommendations for optimal timing of CVS.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 2","pages":"e77-e82"},"PeriodicalIF":0.7,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13056434/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147637971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Application of the After-Action Review Technique for Therapeutic Debriefing after Unscheduled Cesarean Births. 术后回顾技术在非计划剖宫产术后治疗性报告中的新应用。
IF 0.7
AJP Reports Pub Date : 2026-03-30 eCollection Date: 2026-01-01 DOI: 10.1055/a-2837-6754
Elena Lands, Sanjana Ghosh, Anna Binstock, Allison Serra
{"title":"Novel Application of the After-Action Review Technique for Therapeutic Debriefing after Unscheduled Cesarean Births.","authors":"Elena Lands, Sanjana Ghosh, Anna Binstock, Allison Serra","doi":"10.1055/a-2837-6754","DOIUrl":"10.1055/a-2837-6754","url":null,"abstract":"<p><strong>Objective: </strong>While birth-related posttraumatic stress disorder (PTSD) rates are rising, obstetric providers are ill-equipped to lead the trauma response. To address this need, we employed the After-Action Review (AAR) method in semistructured interviews with patients who recently underwent unanticipated cesarean deliveries. We performed qualitative analyses to determine if the AAR technique could (1) provide a therapeutic outlet to patients who experienced trauma and (2) elicit patient-derived quality improvement opportunities.</p><p><strong>Study design: </strong>Twenty patients and their support people were interviewed during the delivery admission, 3 months postpartum, and via an anonymous survey. Two independent coders analyzed transcripts and themes were generated inductively.</p><p><strong>Results: </strong>All surveyed patients found this process helpful, and 80% suggested an improvement, including educating patients about cesareans earlier and designating a specific staff member to support the patient during a cesarean or code. Five main themes emerged: (1) Mental adaptation to new care plan (reported by 95%), (2) prioritizing safety of baby (85%), (3) external influences on birth expectations (70%), (4) importance of support from various team members (85%), and (5) balance between autonomy and desiring definitive recommendations (75% vs. 30%). Interviewers found the technique easy to apply.</p><p><strong>Conclusion: </strong>AAR provides a novel, effective, and reproducible mechanism for therapeutic debriefing and generating patient-centered opportunities to improve care within obstetrics.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 1","pages":"e67-e71"},"PeriodicalIF":0.7,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13035413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147589305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pilot Study Evaluating Associations between Continuous Glucose Monitoring Metrics in Pregnancy and Postpartum A1c and Blood Pressure. 一项评估妊娠期持续血糖监测指标和产后糖化血红蛋白与血压之间关系的初步研究。
IF 0.7
AJP Reports Pub Date : 2026-03-30 eCollection Date: 2026-01-01 DOI: 10.1055/a-2837-6898
Chloe F Michalopoulos, Diana C Soria-Contreras, Sarah Hsu, Robin Azevedo, Arantxa Medina Baez, Emily A Rosenberg, Camille E Powe
{"title":"A Pilot Study Evaluating Associations between Continuous Glucose Monitoring Metrics in Pregnancy and Postpartum A1c and Blood Pressure.","authors":"Chloe F Michalopoulos, Diana C Soria-Contreras, Sarah Hsu, Robin Azevedo, Arantxa Medina Baez, Emily A Rosenberg, Camille E Powe","doi":"10.1055/a-2837-6898","DOIUrl":"10.1055/a-2837-6898","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to examine the relationship between continuous glucose monitoring (CGM) metrics during gestational diabetes mellitus (GDM)-affected pregnancy and postpartum cardiometabolic measures in a pilot study.</p><p><strong>Study design: </strong>We enrolled participants >6 months postpartum from a previous GDM trial where they wore a CGM during the third trimester. At the postpartum visit, we assessed hemoglobin A1c (HbA1c) and blood pressure (BP). We used linear regression models adjusted for age and body mass index (BMI) at the time of CGM wear to test for a relationship between pregnancy CGM metrics (mean glucose, coefficient of variation, time in pregnancy range 63-140 mg/dL [pTIR], time >120 and >140 mg/dL) and postpartum outcomes (HbA1c and BP).</p><p><strong>Results: </strong>Of 14 eligible participants with pregnancy CGM data, 11 (79%) returned at a mean of 20.3 months postpartum (range 11-33). Age and BMI during pregnancy CGM wear were 36.0 (2.7) years and 28.7 (5.5) kg/m <sup>2</sup> ; gestational age was 32.0 (2.0) weeks. Higher pTIR was associated with lower postpartum HbA1c ( <i>n</i>  = 8, β = -0.06, <i>p</i>  = 0.007). Other CGM metrics were not associated with HbA1c. There were no associations between CGM metrics and BP.</p><p><strong>Conclusion: </strong>Third-trimester CGM pTIR should be tested as a predictor of postpartum glycemia in a larger study.</p>","PeriodicalId":7645,"journal":{"name":"AJP Reports","volume":"16 1","pages":"e72-e76"},"PeriodicalIF":0.7,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13035414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147589328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书